ID: ALA12917

Max Phase: Preclinical

Molecular Formula: C11H11Cl2NO

Molecular Weight: 244.12

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC1(C)Cc2cc(Cl)cc(Cl)c2C=[N+]1[O-]

Standard InChI:  InChI=1S/C11H11Cl2NO/c1-11(2)5-7-3-8(12)4-10(13)9(7)6-14(11)15/h3-4,6H,5H2,1-2H3

Standard InChI Key:  UCOILOQSCAMTST-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 244.12Molecular Weight (Monoisotopic): 243.0218AlogP: 3.26#Rotatable Bonds: 0
Polar Surface Area: 26.07Molecular Species: ACIDHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: -0.04CX Basic pKa: CX LogP: 0.45CX LogD: 2.47
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.51Np Likeness Score: 0.27

References

1. Bernotas RC, Thomas CE, Carr AA, Nieduzak TR, Adams G, Ohlweiler DF, Hay DA.  (1996)  Synthesis and radical scavenging activity of 3,3-dialkyl-3,4-dihydro-isoquinoline 2-oxides,  (10): [10.1016/0960-894X(96)00181-3]

Source